Comunicati Stampa
Salute e Benessere

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority)PARIS, July05, 2024(GLOBE NEWSWIRE) -- Listing market: Euronext GrowthISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting rights 06/30/2024100,093,63588,029,364  For further information on Cellectis, please contact:       Media contact:        Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,media@cellectis.com ...
New York, (informazione.it - comunicati stampa - salute e benessere)

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, July 05, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

For further information on Cellectis, please contact:      

Media contact:        

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577

 

Attachment


Per maggiori informazioni
Sito Web
cellectis.com
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili